MicroPort Endovascular updates market on second-phase share repurchase program

As of August 31, 2025, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. has cumulatively repurchased 1,228,743 shares through centralized bidding transactions for its second phase, representing 1.00% of its total share capital. The total amount paid for these repurchases stands at CNY 129,072,779.84, with prices ranging from CNY 84.26 to CNY 120.00 per share.

For the month of August 2025 alone, the company repurchased 137,572 shares, constituting 0.11% of its total share capital. The highest price paid in August was CNY 120.00 per share, while the lowest was CNY 108.01 per share, totaling CNY 15,813,457.94. The repurchased shares are intended for employee stock ownership plans or equity incentives, aligning with the company's approved repurchase plan.

The share repurchase program, initially disclosed on October 30, 2024, has an estimated value between CNY 100 million and CNY 200 million. The repurchase period runs from October 28, 2024, to October 27, 2025. Adjustments to the maximum repurchase price were made due to semi-annual profit distribution, moving from CNY 180.00 to CNY 178.35 and then to CNY 178.01 per share, effective November 8, 2024, and June 6, 2025, respectively.